GBP3-STING Interaction in Glioblastoma in Response to Temozolomide | Oncotarget



October 16, 2023

  • Share
  • Oncotarget published this editorial on May, 2023 in Volume 14, entitled, “GBP3-STING interaction in glioblastoma coordinates autophagy, anti-oxidative, and DNA repair programs in response to temozolomide” by researchers from the Department of Neurosurgery, University of Minnesota, Minneapolis, MN. DOI - Correspondence to - Ming Li - Sign up for free Altmetric alerts about this article - Subscribe for free publication alerts from Oncotarget - Keywords - cancer, GBP3, MGMT, glioblastoma, temozolomide resistance, STING About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, please visit and connect with us: SoundCloud - Facebook - X - Instagram - YouTube - LinkedIn - Pinterest - Reddit - Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

    Cancer ResearchCell ScienceDrug DiscoveryNeuroscience

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.